Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.
Andrei BarbulescuJohan AsklingKaterina ChatzidionysiouHelena Forsblad-d'EliaAlf KastbomUlf LindströmCarl TuressonThomas FrisellPublished in: Rheumatology (Oxford, England) (2022)
Baricitinib and tofacitinib showed at least equivalent effectiveness compared with bDMARDs after exploring several different effectiveness measures.